41. Elsevier.com - Small Animal Cardiology Canine myocardial diseases 6. Feline myocardial diseases 7. Acquired ValvularDiseases 8. Common Congenital Anomalies 9. Pericardial Diseases 10. http://www.elsevier.com/wps/product/cws_home/691183

42. Categorical Course On Cardiopulmonary Imaging — 2005 800 am–1000 am, MRI of myocardial diseases and Cardiac Masses, L. Heyneman.CT and MRI of the Pericardium, L. Broderick. MRI of Valvular Heart Disease http://www.arrs.org/scriptcontent/meeting/2005/courses/catCourse.cfm

Newsline Contact Us Educational Services document.write(dayarray[day]+", "+montharray[month]+" "+date+", "+year) About ARRS AJR Integrative Imaging Technology Forum ... Volunteer with ARRS American Roentgen Ray Society Categorical Course on Cardiopulmonary Imaging Print Schedule Who Should Attend Diagnostic and interventional radiologists and other radiology professionals at all career stages with an interest in diseases of the heart and great vessels as well as diseases of the lungs. Cardiovascular topics include CT and MR imaging of the heart, imaging of the aorta, pulmonary arteries and veins, reading cases with the experts, and how to develop a cardiac imaging service. Thoracic imaging topics include pulmonary embolism, lung cancer, pulmonary infection, radiation dose considerations, imaging in the ICU, applications of high-resolution CT of the lung, and reading cases with the experts. Goals and Objectives Following completion of the program the participant should be able to explain the advantages and disadvantages of MRI of the heart including the myocardium and pericardium, cardiac function, myocardial viability, myocardial perfusion and congenital heart disease. In addition, the attendee should be able to appropriately evaluate the use of CT in imaging of the pericardium, heart, coronary arteries, and congenital heart disease. Participants will be able to evaluate diseases of the aorta, pulmonary arteries and pulmonary veins. Participants should also be able to discuss current imaging techniques in the evaluation of pulmonary embolism, lung cancer, chronic infiltrative lung disease, tuberculosis, infections of the thorax, and diseases of the large and small airways.

43. OpenMED@NIC - Subject: Myocardial Diseases OpenMED is a discipline based Open Access International Archive. It accepts bothpublished and unpublished documents having relevance to research in Medical http://openmed.nic.in/view/subjects/C14.280.600.html

@import url(http://openmed.nic.in/eprints.css); @import url(http://openmed.nic.in/eprints.css); @import url(http://openmed.nic.in/print.css); OpenMED@NIC Home About Browse Search ... Help Subject: Myocardial Diseases Categories Cardiovascular Diseases Heart Diseases Myocardial Diseases Number of records: This list was generated on Fri Sep 9 00:38:02 IST 2005 Bibliographic Informatics Division National Informatics Centre A-Block, CGO Complex, Lodhi Road New Delhi-110 003, India. medinfo@nic.in

44. Canary Database: Browse By Outcome: Myocardial Diseases Browse by Outcome myocardial diseases (1 article) Polychlorinated Biphenyls Search for myocardial diseases outcome Polychlorinated http://canarydatabase.org/browse/outcome/878544

@import url(/wdd_styles.css); Canary Database Animals as Sentinels of Human Environmental Health Hazards PUBLIC BETA Please contact us with your comments. Search: Advanced Search Browse by Author Exposure Journal Methodology ... Year Using the Database Description Take a tour How to search Linkage to human health ... Glossary About the project Mission Related work About us Project team Advisory Board Contact us Canary Database Yale School of Medicine P.O. Box 102283 New Haven, CT Canary Database, Yale School of Medicine P.O. Box 102283 New Haven, CT 06510-2283 Home URL: http://canarydatabase.org/ Home Browse by Outcome : Myocardial Diseases (1 article) % of records by year: Hario M, Hirvi JP, Hollmen T, Rudback E Organochlorine concentrations in diseased vs. healthy gull chicks from the northern Baltic. Environ Pollut. 2004;127(3):411-23 Refine/combine: Show/hide and or Exposure oxychlordane nonachlor, (trans)-isomer

45. The 4th World Congress Of Echocardiography And Vascular Ultrasound Tissue Doppler Tracking System For Analyzing Left Ventricular Segmental WallMotion In Patients With Either Ischemic Or DrugInduced myocardial diseases http://www.egyptheart.org/echo2000/iscu4m_d3a.htm

The 4th World Congress of Echocardiography And Vascular Ultrasound Final SCIENTIFIC PROGRAM Friday January 21st, 2000 Abstract Sessions Search The Program WEDNESDAY JANUARY Program ... Day three Hall D ABSTRACT SESSION - 20 CORONARY HEART DISEASES Chairmen Hassan KHALED, MD (Egypt); Manisha MISHRA, MD (India) Reduced Neurological Injury During CABG in Patients With mobile Aortic Atheromas: A Five Year Follow Up Study. Manisha Mishra. MD; Sameeer Shrivastava, MD; Naresh Trehan, MD Escorts Heart Institute And Research Center, Okhla Road, New Delhi , INDIA # 47 Stress Echocardiography Can Risk Stratify And Prognosticate Patients With Left Ventricular Hypertrophy Varinderp. Singh, Binoy K. Singh, Suman Jaswal, Ellie Haddad, Kathlen Galatro, Farooq A. Chaudhry M. C. P. Hahnemann School Of Medicine, Philadelphia, Pennsylvania, USA. # 48 Transient Left Ventricular Cavity Dilatation During Stress Echocardiography Is A Strong Predictor Of Cardiac Death Binoy K. Singh, Varinderp. Singh,Ugor Izrailtyan, Linda Grosman, Nicole Capozzoli, Medhu Jyothinagaram, Kathleen Galatro, Farooq A. Chaudhry M C. P. Hahnemann School Of Medicine, Philadelphia

46. BUMC Medline Plus/OVID Tutorial: The MeSH terms that are indented under heart diseases are NOT subcategories orsubheadings. Heart Valve Diseases, 2193. myocardial diseases, 2600 http://www.medlib.bu.edu/tutorials/ovid/heartdiseasesexplode1.html

Tutorial Instructions Searchable Questions About MEDLINE Keyword/Textword ... Ordering Articles MeSH TREE Screen 1 of 1 Tree This is the Tree Display . It first shows generic MeSH categories that you can skip over. When you click on CONTEXTS or scroll down the screen, you will see the tree structure for your search term. Tree for Heart Diseases Database: MEDLINE Scroll down for highlighted search term. Select Subject Heading Hits Explode Focus Scope Note Anatomy (Non MeSH) Organisms (Non MeSH) Diseases (Non MeSH) Bacterial Infections and Mycoses Virus Diseases Parasitic Diseases Neoplasms Musculoskeletal Diseases Digestive System Diseases Stomatognathic Diseases Respiratory Tract Diseases Otorhinolaryngologic Diseases Nervous System Diseases Eye Diseases Urologic and Male Genital Diseases Female Genital Diseases and Pregnancy Complications Cardiovascular Diseases Cardiovascular Abnormalities The heart diseases Tree display is hilited below. The MeSH terms that are indented under "heart diseases" are NOT subcategories or subheadings. They are completely independent MeSH Terms. The fact that they are indented under "heart diseases" tells us that these MeSH terms sit in the "heart diseases" family or tree.

47. Cardiovascular Disease Heart Valve Diseases + myocardial diseases + Myocardial Ischemia + PericardialEffusion Pericarditis + Pneumopericardium Postpericardiotomy Syndrome http://www.library.adelaide.edu.au/guide/med/pubhealth/cardio.html

@import "/lib/house.css"; The University of Adelaide Library Guides Help ... Search Public Health Resources by Topic Last update: 5 September 2005, by Maureen Bell Back to: public health index OTHER HEALTH TOPICS Aboriginal and Other Indigenous People's Health Adolescent Health Aged Health Bioethics ... Cancer Cardiovascular Disease Complementary Medicine Consumer Health Information Databases Available to Adelaide University Staff and Students Diabetes ... Women's Health Cardiovascular Diseases I've divided this page into two sections. The first provides you with some tips on searching for material on Medline, and the second provides links to other Australian and overseas web resources, including some full text report and journal literature. Searching Medline You will find material on this subject in Medline, but you will need to be aware of the thesaurus (MeSH) terms used to search for the various topics. Below are some examples of the language Medline uses to describe the concepts in this field. Many concepts have hierarchies of more specific subcategories or related terms. The indentations in the lists reflect the structure of the hierarchy, and the + signs at the end of terms indicate that there is a further hierarchy of terms not displayed here. Any of these terms can be searched individually, or you can "explode" terms to search sections of the list. Cardiovascular Diseases More specific subcategories: Cardiovascular Abnormalities Arterio-Arterial Fistula

48. Cardiothoracic Surgery 1.2.14 Ischemic Heart Disease. 1.2.15 myocardial diseases. 1.2.16 Rheumatic HeartDisease. 1.2.17 Superior Vena Cava Syndrome. 1.2.18 Valvular Disorders http://www.mediligence.com/rpt-c350.htm

Medtech Developments MedMarkets Coverage Published Reports [what is XML?] Methodology Order report online or via order form Markets, Trends, Technologies and Opportunities in Cardiothoracic Surgery April 2003 Report #C350 * 225 pages 67 Exhibits 45 Company Profiles April 2003 Report #C350 This report is a detailed market and technology assessment and forecast of the products and technologies involved in cardiothoracic surgery and repair. The report details the current and emerging products, technologies and markets involved in the spectrum of cardiothoracic procedures. The report covers the products and technologies on the market and under development, encompassing visualization equipment, robots, heart-lung machines, beating heart stabilization equipment, mechanical implant systems, tissue implants, and the emerging technologies of synthetic materials, biological therapies. The report provides a current and forecast assessment of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade. Executive Summary Overview U.S. Cardiovascular Disease Market

49. Supraventricular Tachycardias Atrial tachycardia occurs in some patients with myocardial diseases during systemicarterial hypoxia and in some patients with serious mitral valve disease. http://www.americanheart.org/presenter.jhtml?identifier=59

50. Medical Research In Zambia Keywords Myocard Ischemia/ myocardial diseases/Coronary Disease/ Heart Diseass/Infarction/ Myocardial Infarction/ Male/ New Zealand/ White Rabbits/ http://www.medguide.org.zm/zamresh/resh2.htm

University of Zambia Medical Library Medical Research in Zambia Author: Goma, Fastone Mathew Title: Effect of Adding Isometric ( static ) Excercise to Dynamic Exercise in Ischaemic Heart Disease. Thesis (Ph.D) Imprint: Leeds : University of Leeds Research School of medicine, Institute for Cardiovascular Research, 1998. Status: Unpublished Location: University of Zambia Medical Library Keywords: Heart Diseases/ Isometric Contraction/ Exercise/ Exercise Test/ Exertion/ Myocardial Contraction/ Myocardial Diseases Abstract: Author: Goma, Fastone Mathew Title: Characterisation and Mechanisms of the Delayed Phase of Myocardial Protection Following Ischaemic Preconditioning. Thesis ( Msc. ) Imprint: London : University Colege of London, Department of Physiology, 1994.. Status: Unpublished Location: University of Zambia Medical Library Keywords: Myocard Ischemia/ Myocardial Diseases/Coronary Disease/ Heart Diseass/ Infarction/ Myocardial Infarction/ Male/ New Zealand/ White Rabbits/ Phosphotransferases/Protein Kinases/ Reperfusion Injury Abstract: Background: Repeated short periods of coronary ischaemia protect the myocardium against subsequent sustained ischaemia. This phenomenon, termed ischaemic preconditioning, has been seen to be protective not only against myocardial necrosis but also against ischaemia/ reperfusion arrhymias, post-ischaemic contractile dysfunction “ stunning “ and abnormalities in myocardial perfusion. This protection has been seen to be biphasic. The “ classical “ protection is evident within 5 minutes of reperfusion but is transient and disappears within 1- 2 hours. However, it has been observed that 24 hours later there is , again, enhanced protection against sustained ischaemia ( the “ second window of protection “ ). The time course of this delayed phase of myocardial protection is undetermined and so is/ are the mechanism ( s ) underlying it. Protection Kinase C has been shown to be in the “classical “ protection and is thought to vital in the mechanisms underlying the protection mediated by preconditioning.

51. Cardiology Services At WSU Degenerative valvular disease; Primary myocardial diseases (hypertrophic,restrictive and dilated cardiomyopathy); Congestive heart failure patients http://www.vetmed.wsu.edu/announcements/cardio.asp

Washington State University Home Cardiology Services O. Lynne Nelson, DVM, MS Diplomate, American College of Veterinary Internal Medicine Cardiology Procedures/ Diagnostics offered at WSU: Dr. Nelson will predominantly see small animal patients but will also evaluate other species, including horses and some exotic patients such as ferrrets. General cardiovascular evaluation: complete cardiovascular examination, chest radiography, electrocardiography, blood pressure measure Echocardiography: (2D, Mmode, spectral and color Doppler, and contrast imaging) Occasional stress testing, Digital storage and archiving echo exams Cardiac catheterization: for diagnostic information, obtaining pressures and/or performing contrast studies for complex heart diseases and congenital anomalies. Interventional procedures: Balloon dilation valvuloplasty, pacemaker placement, percutaneous balloon pericardiotomy Types of Cases Evaluated at WSU: Degenerative valvular disease Primary myocardial diseases (hypertrophic, restrictive and dilated cardiomyopathy)

52. Congestive Heart Failure ischemic heart disease and myocardial infarction are the most common. infectious or inflammatory myocardial diseases, diabetes, thyroid disease, http://www.sh.lsuhsc.edu/fammed/OutpatientManual/CongestiveHeartFailure.htm

Congestive Heart Failure Objectives After completion of this module the student should be able to: 1. List medical conditions that may result in heart failure. 2. Identify common symptoms of heart failure. 3. Describe physical findings suggestive of heart failure. 4. Discuss basic drug classes used in treating heart failure. Introduction Heart failure results when, provided adequate venous return, the heart is unable to pump enough blood to meet the oxygen demands of the body. The underlying causes are many and often complex. Treatment generally is focused on symptomatic relief and management of contributing medical factors. Evaluation Of the many causative factors for heart failure, chronic hypertension, ischemic heart disease and myocardial infarction are the most common. Other causes or contributing factors include toxic, infectious or inflammatory myocardial diseases, diabetes, thyroid disease, anemia and valvular heart disease. The diagnosis of heart failure should be considered when there is a history of any of these conditions accompanied by fatigue, fluid retention, decreased exercise endurance, orthopnea, paroxysmal nocturnal or exertional dyspnea, nocturia or confusion. Once heart failure is suspected, evaluation should include the following tests:

53. Basic Research - Neufeld Cardiac Research Institute/Tau - Medicine and adult stem cells, for cellbased therapy of myocardial diseases. may underlie disease states as ischemia-reperfusion myocardial hibernation, http://www.tau.ac.il/medicine/neufeld-cardiac/basic.html

Basic Research on site facilities for: cardiac catheterization and electrophysiology, biochemical assays, tissue and cell culture, gene transfer, evaluation of gene transfer expression, cell transplantation, and animal care. Senior Investigators: Jonathan Leor, M.D. Mickey Scheinowitz, Ph.D. Malca Cohen-Armon, D.Sc. Giora Amitzur, Ph.D. ... David Castel, DVM. Research projects that are currently under investigation at the institute include: Genetic modulation, cell transplantation and tissue engineering promise a revolutionary approach for myocardial regeneration and tissue repair after myocardial injury. Current data derived from animal models suggest that it may be possible to treat heart failure by inserting genetic materials or myogenic cells into injured myocardium. Success with animal models has raised the hope for new treatment after heart attacks and could prove an alternative to transplantation, particularly in elderly patients for whom there is often a lack of donor hearts. Cell transplantation is a promising strategy to increase viability and augment ventricular function after myocardial infarction. Cells subjected to genetic modification could also be used for the long-term delivery of therapeutic recombinant proteins to the heart providing an alternative strategy for gene therapy. Stem cells are a unique population of cells characterized by their pluripotency, i.e., the ability to differentiate into multiple cell lineage. Stem cells are unlimited in number since they have self-regenerating capacity and can be expanded

54. UCLA Cardiology Fellowship Training Program - Faculty Specialties Adult congenital heart disease; valvular and hypertrophic myocardial diseases;aortic diseases; transesophageal echocardiography. JESSE W. CURRIER, MD http://www.cardiology.med.ucla.edu/fellowship/faculty_specialties.htm

Faculty Training Programs Other Links Research ... Cardiology Fellowship Training Program UCLA CARDIOVASCULAR FELLOWSHIP Faculty and Research Specialties JAMES N. WEISS, M.D. * Chief, Division of Cardiology Director, Cardiovascular Research Laboratory Kawata Professor of Medicine and Physiology Cardiac electrophysiology; myocardial ischemia; mitochondrial physiology ion channels; experimental arrhythmias; nonlinear dynamics JESUS A. ARAUJO, M.D., Ph.D. Clinical Instructor of Medicine Noninvasive cardiology, transesophageal echocardiography; vascular biology; study of genes involved in vascular inflammation associated with atherosclerosis and cardiac transplantation RALUCA ARIMIE, M.D.

55. MedtechInsight.com - Reports 1.3 myocardial diseases/Disorders. 1.3.1 Congestive Heart Failure. 1.3.2 HeartValve Disorders. 1.3.3 Congenital Cardiovascular Defects http://www.medtechinsight.com/ReportA215.html

Search The Newsletter The Principals Reports ... Pricing and Ordering Information U.S. Markets for Cardiovascular Disease Diagnostic Products May 2004, 382 pages Report #A215 More adults in the U.S. die from cardiovascular diseases/disorders than from any other cause. Nationwide, approximately 64.4 million people have at least one cardiovascular condition; these diseases/disorders kill nearly 2,600 people in the U.S. each day, and result in direct and indirect costs that exceed $368.0 billion annually. In 2003, more than 154.7 million electrocardiography, endovascular, noninvasive diagnostic imaging, and near patient in vitro testing procedures were performed in the U.S. to diagnose cardiovascular diseases/disorders. These procedures generated approximately $3.6 billion in corresponding product sales, with noninvasive diagnostic imaging systems sales accounting for 45.8% of the total, imaging contrast agents and biopharmaceuticals sales for 21.9%, transcatheter diagnostic systems sales for 17.4%, near patient in vitro testing products sales for 7.9%, and electrocardiography systems sales for 7.0%. Growing at a compound annual rate of 8.0%, sales of these products are expected to reach an estimated $4.8 billion in the year 2007.

56. MedtechInsight.com - Reports 2.1.3 Ischemic Heart Disease. 2.1.4 Angina Pectoris. 2.1.5 Myocardial Infarction.2.1.6 Stroke 2.3 myocardial diseases. 2.3.1 Congestive Heart Failure http://www.medtechinsight.com/Report1407.html

Search The Newsletter The Principals Reports ... Pricing and Ordering Information European Markets for Cardiovascular Diagnostics, May 2000, 400 pages Report #RP-481407 Cardiovascular diseases impose a heavy socioeconomic burden on European healthcare systems. In the five largest European countries, France , Germany, Italy, Spain, and the United Kingdom, a total of $110 to $115 billion is spent annually for the management of cardiovascular disorders. Of this total, approximately $40 billion is spent for treating coronary heart disease, more than $15 billion for stroke, $12 billion for hypertensive disease, and approximately $8 billion for congestive heart failure. Cardiovascular diagnostic product sales, including electrocardiography, noninvasive imaging, and intravascular techniques, generated more than $1.4 billion in 1999 for the five major countries of Europe. Reimbursement has historically led to significantly different competitive product profiles and pricing across Europe . With the impact of greater regulatory harmonization, reduced trade barriers, the euro, and European regulations, new ways of positioning products across

57. Nature Clinical Practice Cardiovascular Medicine | Hypertrophic Cardiomyopathy I His main fields of interest include primary myocardial diseases, hypertrophiccardiomyopathy, microvascular angina and heart failure. http://www.nature.com/ncpcardio/journal/v2/n7/authors/ncpcardio0248.html

@import "/common/style/layout.css";/* do not edit this stylesheet */ @import "/common/style/main.css";/* do not edit this stylesheet */ @import "/clinicalpractice/style/layout_group.css";/* do not edit this stylesheet */ @import "/clinicalpractice/style/group.css";/* do not edit this stylesheet */ @import "/ncpcardio/style/site.css";/* edit this stylesheet only */ Accessibility statement Jump to main content Jump to main navigation Jump to search ... ABOUT NPG E-MAIL: PASSWORD Save password Forgotten password? MY ACCOUNT E-ALERTS SUBSCRIBE ... REGISTER Text to search for Advanced search Full text of this article is available with one of the following: Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access. 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above. Site licence Learn more about institutional site licences Current Subscribers Please login to access the full text article using the login box at the top of the page.

58. The Heart Of Genomics - Nature Medicine myocardial diseases. Circulation 102, 3439 (2000). ISI ; The internationalSNP map working group. A map of human genome sequence variation containing http://www.nature.com/nm/journal/v7/n3/full/nm0301_287.html

@import "/nm/style.css"; NATURE.COM NEWS@NATURE.COM NATUREJOBS NATUREEVENTS ... Help E-MAIL: PASSWORD: Save password Forgotten password? SEARCH JOURNAL Advanced search Journal home Archive Table of Contents ... For librarians NPG Resources Nature Nature Reviews Nature Immunology Nature Cell Biology ... Browse all publications News and Views Nature Medicine doi:10.1038/85420 The heart of genomics michel.komajda@psl.ap-hop-paris.fr The completion of the Human Genome Project will provide much needed insight into the molecular basis of monogenic or complex cardiac disorders. But what are the prospects for using genomic information in diagnosis and treatment of cardiac diseases? Cardiovascular disorders represent a large public health concern due to their high prevalence, morbidity and mortality. Due to increases in life expectancy, diseases such as hypertension, coronary artery disease, heart failure, stroke and peripheral vascular diseases have become pandemic in both developed and developing countries. The publication of the human genome draft sequence is a scientific contribution of unprecedented scale that will provide insight into the genetic basis of many human diseases. Although the way in which it will affect cardiovascular medicine is uncertain, it is a question of paramount importance, due to the socio-economic impact of these disorders.

59. Myocardial Diseases -- Roberts And Schwartz 102 (Supplement 4): 34 -- Circulatio myocardial diseases. Robert Roberts, MD ; Ketty Schwartz. From the Department ofMedicine, Baylor College of Medicine, Houston, Tex. http://circ.ahajournals.org/cgi/content/full/102/suppl_4/IV-34

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal ... Request Permissions PubMed PubMed Citation Articles by Roberts, R. Articles by Schwartz, K. Related Collections Clinical genetics Cardiac development Hypertrophy Genetics of cardiovascular disease ... Functional genomics Circulation. 2000;102:IV-34.) Special Anniversary Issue Myocardial Diseases Robert Roberts, MD Ketty Schwartz From the Department of Medicine, Baylor College of Medicine, Houston, Tex. Correspondence to Robert Roberts, MD, Department of Medicine, Baylor College of Medicine, 6550 Fannin, MS SM-677, Houston, TX 77030 Key Words: As we enter into the new millennium, the aura of molecular genetics conjures up an exciting and challenging future for the cardiologist. The prospects for improvement in the diagnosis, prevention, and treatment of cardiovascular disease are limited only by our present knowledge and imagination. Speculations on the future

60. Myocardial Diseases Terms And Definitions At Www.MedicalGlossary.org Also Called, Cardiomyopathies,myocardial diseases, Primary,Secondary MyocardialDiseases Cardiomyopathy, Restrictive Myocardial disease in which the http://www.medicalglossary.org/heart_diseases_myocardial_diseases_definitions.ht

Home Diseases Cardiovascular Diseases Heart Diseases Myocardial Diseases Definition: Diseases of the myocardium. Notes: GEN; prefer specifics; for infections of the myocardium, coord here (IM) with infection term (IM), not with HEART DISEASES Also Called: Cardiomyopathies,Myocardial Diseases, Primary,Secondary Myocardial Diseases Myocardial Diseases Categories. Cardiomyopathy, Alcoholic - Cardiomyopathy resulting from: (1) a toxic effect of alcohol on the myocardium; (2) thiamine deficiency due to malnutrition in alcoholics; or (3) a toxic effect of cobalt additives in beer in heavy beer drinkers. This disease is usually manifested by dyspnea and palpitations with cardiomegaly and congestive heart failure. Cardiomyopathy, Restrictive - Myocardial disease in which the ventricular walls are excessively rigid, impeding ventricular filling; it is marked by abnormal diastolic function but by normal or nearly normal systolic function. Endocardial Fibroelastosis - A condition characterized by hypertrophy of the wall of the left ventricle and conversion of the endocardium into a thick fibroelastic coat, with the capacity of the ventricle sometimes reduced, but often increased. (Dorland, 27th ed) Endomyocardial Fibrosis - A disease characterized by thickening of the endocardium, and frequently the inner third of the myocardium. The left ventricle is most frequently involved. Cardiomegaly and congestive heart failure may also be present.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 3     41-60 of 101    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20